In this study, the 5-year recurrence-free survival of advanced UTUC was approximately 60% in the SPARCL1-positive group, whereas it was approximately 35% in the SPARCL1-negative group (presented as Kaplan Meier plot in Figure 3D). The gene discussed is SPARCL1; the disease is renal pelvis/ureter urothelial carcinoma.